| Jenna Wonsowicz, DO | |
|
27351 Dequindre Rd, Madison Heights, MI 48071-3487 | |
| (248) 967-7661 | |
| (248) 967-7876 |
| Full Name | Jenna Wonsowicz |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 27351 Dequindre Rd, Madison Heights, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194215657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101025779 (Michigan) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Observation Emergency Physicians Pc | 9133292410 | 45 |
| Emergency Department Physicians Pc | 9436048998 | 66 |
News Archive
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.
Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have found a new method for obtaining high-quality images in magnetic resonance imaging, that requires less contrast medium compared to current methods.
SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.
› Verified 9 days ago
| Entity Name | Emergency Department Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225083595 PECOS PAC ID: 9436048998 Enrollment ID: O20040312000466 |
News Archive
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.
Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have found a new method for obtaining high-quality images in magnetic resonance imaging, that requires less contrast medium compared to current methods.
SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.
› Verified 9 days ago
| Entity Name | Observation Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497920524 PECOS PAC ID: 9133292410 Enrollment ID: O20080719000024 |
News Archive
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.
Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have found a new method for obtaining high-quality images in magnetic resonance imaging, that requires less contrast medium compared to current methods.
SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Wonsowicz, DO 29656 Newport Dr, Warren, MI 48088-8503 Ph: (586) 201-6513 | Jenna Wonsowicz, DO 27351 Dequindre Rd, Madison Heights, MI 48071-3487 Ph: (248) 967-7661 |
News Archive
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.
Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have found a new method for obtaining high-quality images in magnetic resonance imaging, that requires less contrast medium compared to current methods.
SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.
› Verified 9 days ago
Elizabeth Ann Marcuz, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7000 | |
Kimberly F Heller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7661 | |
Arash Yekrangi-tajvidi, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Sergey Tsekhanov, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Matthew Boutorwick, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795 Fax: 248-967-7794 | |
Gino Shwkat Etta, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7661 Fax: 248-967-7876 |